COMP <GO>
NEOG vs ORKA // ENTERPRISE SCALE & MARKET CAP
Neogen Corporation (NASDAQ) VS. Oruka Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: NEOG 6
— ORKA 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ORKA
LAST: $11.82 (0.00%) • MKT CAP: $2.58B
market-cap
$2.58B
LAST: $95.43 (-1.49%) • MKT CAP: $6.41B
market-cap
$6.41B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEOG VS. ORKA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEOG | ORKA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -0.60% | -18.80% | +18.20 | NEOG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | -1.38% | +4.49 | NEOG | /fcf-yield <GO> |
| Operating Margin | -2.50% | -6.80% | +4.30 | NEOG | /operating-margins <GO> |
| Net Profit Margin | -0.90% | -5.90% | +5.00 | NEOG | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | -4.40% | +1.70 | NEOG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.45 | 26.00 | -24.55 | ORKA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | NEOG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 67.0 | -21.10 | ORKA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.13 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 28.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.58B | $6.41B | -$3.83B | ORKA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEOG REV | ORKA REV | NEOG GROSS % | ORKA GROSS % | NEOG FCF | ORKA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $870.4M | $341.7M | 46.9% | — | $83.2M | -$88.4M |
| FY 2024 | $894.7M | $246.7M | 47.1% | — | $58.2M | -$58.0M |
| FY 2023 | $924.2M | $20.4M | — | — | $35.3M | -$5.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEOG // BETA —
ORKA // BETA 1.13